Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HMG for Sperm DNA Fragmentation in Idiopathic Infertility
NCT07873502Phase 1Completed
- Sponsor
- Jinling Hospital
- Start
- Jul 2025
- Primary completion
- Oct 2025
- Countries
- 1
01
Overview
Phase 1 trial of human menopausal gonadotrophin in male infertility (2 arms), sponsored by Jinling Hospital. Primary endpoint: Sperm DNA Fragmentation Index at 3 months. Started Jul 2025; status: completed.
02
Drugs
human menopausal gonadotrophin
03
Conditions
male infertility
Beyond the preview
Go deeper on NCT07873502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07873502.